Priority Date: 02.02.12 (US 201261594023P)

CDK8/CDK19 SELECTIVE INHIBITORS AND THEIR USE IN ANTI-METASTATIC AND CHEMOPREVENTATIVE METHODS FOR CANCER

  • Application ID: EP13704538
  • Status: The patent has been granted

Attorney

operating since 1974
Headquarter in Munich
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 228 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 02.02.2012 - Priority Date (US 201261594023P)
  • 08.08.2013 - Publication A1 (WO2013116786)
  • 10.12.2014 - Publication A1 (EP2809324)
  • 01.08.2018 - Publication B1 (EP2809324)

IPC Classification